[EN] COMPOUNDS AND METHODS FOR INHIBITING JAK<br/>[FR] COMPOSÉS ET PROCÉDÉS D'INHIBITION DE JAK
申请人:ASTRAZENECA AB
公开号:WO2017050938A1
公开(公告)日:2017-03-30
Disclosed are compounds of formula (I), pharmaceutical compositions comprising such compounds and methods/uses of using the same, for example, for treating a JAK-related disorder, such as cancer, cancer cachexia or an immune disorder: (I) wherein R1 is methyl or ethyl; R2 is selected from methyl, ethyl, methoxy and ethoxy; R3 is selected from hydrogen, chlorine, fluorine, bromine and methyl; R4 is selected from methyl, ethyl and -CH2OCH3; R5 and R6 are each individually methyl or hydrogen; and R7 is selected from methyl, ethyl, -(CH2)2OH and –(CH2)2OCH3, or a pharmaceutically acceptable salt thereof.
公开的是公式(I)的化合物,包括含有这些化合物的药物组合物以及使用这些化合物的方法/用途,例如用于治疗JAK相关疾病,如癌症、癌症恶病质或免疫紊乱:(I)其中R1是甲基或乙基;R2选择自甲基、乙基、甲氧基和乙氧基;R3选择自氢、氯、氟、溴和甲基;R4选择自甲基、乙基和-CH2OCH3;R5和R6分别是甲基或氢;R7选择自甲基、乙基、-(CH2)2OH和-(CH2)2OCH3,或其药用盐。